High levels of antiretroviral therapy (ART) adherence are required to achieve optimal viral suppression. To better understand mechanisms associated with ART adherence, this study characterized demographic and socialcognitive correlates of ART adherence among HIV-infected individuals from a medium-sized northeastern US city (n 0116; 42% female; 43% African-American). Participants completed an audio computer-assisted selfinterviewing survey assessing demographics, social-cognitive constructs, and ART adherence, and the participants' most recent viral load was obtained from their medical charts. Suboptimal ART adherence (taking less than 95% of prescribed medications during the past month) was reported by 39% of participants and was associated with being female, being a minority, and having a detectable viral load. In a hierarchical logistic regression analysis, greater than 95% ART adherence was associated with higher levels of adherence self-efficacy (AOR 0 1.1; p 00.015), higher perceived normative beliefs about the importance of ART adherence (AOR 01.3; p 00.03), and lower concern about missing ART doses (AOR 00.63; p 00.002). Adherence did not differ based on ART outcome expectancies, ART attitudes, or the perceived necessity of ART. In fact, most participants endorsed positive attitudes and expectancies regarding the need for and effectiveness of ART. Taken together, results indicate that suboptimal adherence remains high among HIV-infected minority women, a subpopulation that experiences particularly high rates of chronic stress due to both illness-specific stressors and broader environmental stressors. Consistent with social-cognitive theory, adherence problems in our sample were linked with deficits in self-efficacy as well as perceived norms and behavioral intentions that do not support a goal of 100% adherence. We suggest that interventions to improve adherence informed by social-cognitive theory (1) target patients who are at risk for adherence problems, (2) provide a supportive environment that promotes high rates of adherence, and (3) address inaccurate beliefs regarding optimal adherence levels.
Despite increased HIV-prevention efforts, rates of new infections remain relatively stable, with approximately 50,000 new HIV infections diagnosed in the United States (US) annually (Prejean et al., 2011) and more than 1 million individuals living with HIV in the US (CDC, 2010) . Antiretroviral therapy (ART) has improved the longevity of HIV-infected individuals and markedly decreased HIV-related mortality (Palella et al., 1998; Schackman et al., 2006) . However, ART medications require high levels of adherence to maintain viral suppression and prevent the development of drug-resistant HIV strains (Balfour et al., 2006; Clavel & Hance, 2004; Paterson et al., 2000) . While optimal ART adherence rates vary by drug type (Bangsberg, 2006; Bangsberg, Kroetz, & Deeks, 2007) , an adherence level of 95% or greater is consistently associated with optimal viral suppression across ART drug types (Krakovska & Wahl, 2007; Low-Beer, Yip, O'Shaughnessy, Hogg, & Montaner, 2000; Paterson et al., 2000) .
Since suboptimal ART adherence increases the risk for negative health outcomes, efforts to identify factors associated with adherence are urgently needed. Diverse correlates of ART adherence have been examined, including demographic characteristics (Barclay et al., 2007; Kamau, Olson, Zipp, & Clark, 2011) , mental health, or substance use difficulties (Murphy, Greenwell, & Hoffman, 2002; Reynolds et al., 2004) ; psychosocial functioning (e.g., social support; Finocchario-Kessler et al., 2011; Simoni, Frick, Lockhart, & Liebovitz, 2002) , and other health conditions (e.g., comorbid pain; Berg, Cooperman, Newville, & Arnsten, 2009 ). Prominent theoretical frameworks to explain ART adherence include the information-motivation-behavior model (Fisher, Fisher, Amico, & Harman, 2006) , social problem solving framework (Johnson, Elliott, Neilands, Morin, & Chesney, 2006) , and the stress and coping model (Johnson, Heckman, Hansen, Kochman, & Sikkema, 2009 ). In addition, there is a growing literature examining the extent to which core constructs from social-cognitive theory (SCT) (Bandura, 1977 (Bandura, , 2004 are associated with ART adherence.
SCT postulates that personal characteristics, social interactions, and behavioral factors interactively determine health behavior engagement (Bandura, 2004) . Central to SCT is self-efficacy, or one's confidence in his/her ability, to engage in a particular behavior under various circumstances (Bandura, 1977) . Self-efficacy has been studied as a correlate of ART adherence, with greater self-efficacy levels to consistently take ART medications associated with better ART adherence (Barclay et al., 2007; Catz, Kelly, Bogart, Benotsch, & McAuliffe, 2000; Fumaz et al., 2008; Gifford et al., 2000; Godin, Cote, Naccache, Lambert, & Trottier, 2005; Murphy et al., 2002; Rudy, Murphy, Harris, Muenz, & Ellen, 2010; Simoni, Frick, & Huang, 2006) . Outcome expectancies, defined as an individual's appraisal of potential consequences for a behavior, influence whether a behavior is performed or not (Bandura, 2004) . Expectancies for negative ART outcomes (e.g., medication side effects) have been linked to poor adherence (Catz et al., 2000; Murphy et al., 2002; Rudy et al., 2010) . SCT suggests that individuals with greater self-efficacy and positive outcome expectancies will influence one's beliefs and attitudes toward a behavior (Bandura, 2004) . For instance, positive medication attitudes have been associated with improved ART adherence (Godin et al., 2005) . Moreover, more permissive attitudes about the importance of ART adherence may be indicative of a higher vulnerability for suboptimal adherence (Malcolm, Ng, Rosen, & Stone, 2003) .
While a number of studies have examined individual SCT constructs (e.g., self-efficacy) as correlates of ART adherence, there is a dearth of empirical research examining the application of a broader set of SCT constructs to ART adherence. To our knowledge, only a single study has evaluated the utility of a comprehensive SCT model of ART adherence (DiIorio et al., 2009) . In addition to modeling the relationship between self-efficacy and outcome expectancies to ART adherence, DiIorio and colleagues examined the role of depression levels and related psychosocial constructs (e.g., stigma). Self-efficacy and depression were directly related to ART adherence, and the related constructs (i.e., stigma, patient satisfaction, and social support) were indirectly linked to ART adherence via self-efficacy or depression (DiIorio et al., 2009) . While this study highlights the role of depression and other psychosocial factors in relationship to ART adherence, there is a need to further examine the extent to which core SCT constructs (i.e., self-efficacy and outcome expectancies) and related attitudes, beliefs, and norms are associated with ART adherence.
Thus, to better understand mechanisms associated with ART adherence, this study examined socialcognitive factors associated with ART adherence among HIV-infected individuals. Consistent with SCT, we predicted that greater ART adherence selfefficacy and positive outcome expectancies would be associated with higher ART adherence levels. This study also examined demographic differences in ART adherence and the association between ART adherence and participants' health status.
Methods

Procedures
Participant recruitment
Patients were recruited during outpatient medical visits at a university-based infectious disease (ID) clinic in Syracuse, New York, a mid-sized northeastern city, or via letter for patients who participated in prior studies and agreed to be recontacted. Figure 1 provides a CONSORT diagram of participant recruitment and enrollment. Patients were informed that participation involved completing a computerized survey of HIV-related health practices. Eligibility requirements for this study were the following: (1) receiving outpatient care at the ID clinic; (2) 18 years or older; (3) English-speaking; and (4) medically and cognitively capable of participation. For this study, analyses were limited to participants reporting current ART use (N 0116). All participants provided written informed consent and were compensated $20 for their time and travel. All study procedures were approved by the institutional review boards of the participating institutions.
Survey administration
The questionnaire battery was administered using audio computer-assisted self-interviewing (ACASI) in a private assessment room. The survey took approximately one hour to complete (range: 45 minutesÁ2 hours).
Measures
Demographic characteristics
Participants reported their gender, ethnicity, age, current employment status, annual income, and the number of years since receiving their HIV diagnosis.
Patients approached (n = 253) Approached by ID clinic staff (n = 143) Sent letter regarding the study (n = 110)
Declined participation prior to screening (n = 4) Unable to reach patient regarding study interest (n = 71)
Currently prescribed ART regimen (n = 116)
Not currently prescribed ART regimen (n = 39)
Unable to participate due to schedule conflicts and/or transportation issues (n = 28)
Assessed for eligibility (n = 178)
Met eligibility criteria (n = 178)
Consented and completed study (N = 150) 
Medical chart data
Medical chart data collected included the following:
(1) current ART regimen medications;
(2) number of ART pills prescribed; (3) most-recent viral load (undetectable: B50 copies RNA/mL or detectable: 50 copies RNA/mL); and (4) medical providers' notation of any ART-associated adherence problems (yes/no).
ART adherence
The measure of ART adherence was informed by a review of self-report ART adherence measurement (Simoni, Kurth, et al., 2006) . Participants reported their level of ART adherence during the past month by completing a visual analog scale (0Á100%) in which they rated how much of their HIV medications they took. Responses were dichotomized to reflect optimal (i.e., taking 95Á100% of ART doses; coded as 1) versus suboptimal (i.e., taking less than 95% of ART doses; coded as 0) adherence levels.
ART adherence self-efficacy ART adherence self-efficacy was measured by a 12item scale (Johnson et al., 2007) . Participants rated their confidence to maintain ART adherence in different situations (e.g., ''Stick to your treatment schedule even when your daily routine is disrupted'') from 1 (not confident at all) to 4 (completely confident I can do it). A total score across items was calculated, with higher scores indicating greater levels of ART adherence self-efficacy (a 01.0).
ART outcome expectancies
Six items were developed for the present study to assess outcome expectancies for ART on long-term health outcomes. A sample item includes, ''If you did not take your HIV medications as they are prescribed to you, how likely is it that your immune system would get weaker?'' Participants rated their outcome expectancies from 1 (not at all likely) to 4 (very likely) with scores summed across items. Higher scores were indicative of more negative outcome expectancies for ART nonadherence (a 00.73).
Attitudes toward ART nonadherence
Eleven items assessed participants' attitudes and beliefs about ART adherence. Items measured beliefs reflecting permissive attitudes toward adherence and the perceived risks of nonadherence (e.g., ''Some people make a big deal about taking HIV medications ''perfectly,'' but it really isn't that important.'') For each item, participants indicated the extent to which they agreed or disagreed using a 6-point Likert scale with response options ranging from ''Strongly Agree'' to ''Strongly Disagree.'' Higher scores on this measure were indicative of greater perceived risks of nonadherence (a 00.64).
Perceived necessity of ART
Participants' beliefs regarding the perceived necessity of ART were measured with an 8-item scale (Horne et al., 2004; Horne, Cooper, Gellaitry, Date, & Fisher, 2007) . A sample item includes, ''My health in the future depends on HIV medications.'' Participants rated their agreement with each statement from 1 (strongly disagree) to 6 (strongly agree). A total score was calculated, with higher scores indicating greater perceived ART necessity (a 00.80).
ART adherence normative beliefs
Two items assessed perceived norms surrounding optimal ART adherence levels. First, participants identified what they believe is an optimal rate of adherence (i.e., ''Based on what you personally believe, not just what your doctor tells you, what is a good rate of adherence?'') and provided a rating from 0 to 100%. Second, participants reported on the number of missed ART doses that would be of concern out of 10 possible future doses and provided a number between 0 and 10 for their response (Graham, Bennett, Holmes, & Gross, 2007) .
Data analyses
Descriptive statistics were calculated to describe social-cognitive factors, current ART adherence levels, and related health status variables. Next, bivariate analyses compared the participants who endorsed optimal ART adherence levels (i.e., taking 95Á100% of prescribed ART doses in the past month) and those who endorsed suboptimal adherence levels (i.e., taking less than 95% of prescribed doses in the last month) on demographic characteristics and health status variables. Bivariate analyses then examined differences in social-cognitive constructs between the optimal and suboptimal adherence groups. Independent samples t-tests examined differences between groups for continuous variables and chi-square analyses examined differences between groups for categorical outcomes. Social-cognitive factors significantly associated with adherence levels at the bivariate level (p B0.10) were then entered into a multivariate, logistic regression analysis, controlling for significant demographic differences and ART regimen characteristics between groups.
Results
Participant characteristics
HIV-infected individuals (N 0116; 40% female, 58% male, and 2% transgender) participated in the study, with 43% self-identifying as AfricanÁAmerican, 47% Caucasian, 4% American Indian or Alaskan Native, 2% Native Hawaiian or Other Pacific Islander, and 4% as multiracial. Ten percent of participants identified as Hispanic. Participants' ages ranged between 21 and 64 (M age 045.3, SD08.6). Sixtytwo percent were unemployed and 63% reported a yearly income of less than $10,000. The average number of years since being diagnosed with HIV was 12.3 years (SD06.2).
Descriptive statistics
Sixty-one percent had taken ART for more than seven years and 7% for less than one year. Medical chart data reflected that participants were prescribed an average of 2.6 ART pills per day (SD 00.96, range 01Á5). According to participants' medical charts, 72% had an undetectable viral load and 28% had a detectable viral load at their last medical visit. Medical providers noted ART adherence problems in the medical charts of 48% of participants. Participants reported taking an average of 89.7% of their prescribed ART medications during the last month (SD 018.3; range 00Á100). Suboptimal ART adherence (i.e., taking less than 95% of prescribed medications during the last month) was reported by 39% of participants. Table 1 provides descriptive statistics for SCT constructs. On average, participants reported the perception that, regardless of what their doctor tells them, an optimal rate of adherence is 94% (range 050Á100; SD 013.6). Of the possible 10 doses, participants indicated that 2.2 missed ART doses (range 00Á10; SD 02.7) would be of concern.
Differences in adherence levels by sociodemographic characteristics and health status variables
First, bivariate analyses examined potential differences in adherence levels by demographic characteristics and health status variables (see Table 2 ). Women and racial minorities were more likely to endorse suboptimal ART adherence than men and Caucasian individuals. There were no differences in adherence by age, current employment status, or monthly income. Participants reporting optimal AIDS Care 1153 adherence levels were more likely to have an undetectable viral load at their last medical appointment, were more likely to report being on ART for fewer years, and were taking fewer ART pills than individuals with lower adherence levels.
Social-cognitive correlates of ART adherence Bivariate analyses
First, bivariate analyses examined differences in social-cognitive constructs between individuals with suboptimal ART adherence and those with optimal ART adherence levels (see Table 3 ). Participants with optimal adherence levels endorsed: (1) greater ART adherence self-efficacy; (2) more negative outcome expectancies for ART nonadherence; (3) greater perceived risk of ART nonadherence; (4) greater perceived need for ART; (5) higher levels of optimal ART adherence; and (6) fewer number of missed ART doses that would be of concern.
Multivariate analyses Table 4 displays results from a hierarchical logistic regression analysis controlling for participant gender, ethnicity, years on ART, and number of daily ART pills. Greater than 95% ART adherence was associated with higher levels of adherence self-efficacy (AOR 01.1, 95% CI 01.02Á1.2), higher perceived normative beliefs about the importance of ART adherence (AOR 01.3, 95% CI 01.02Á1.5), and fewer acceptable missed ART doses (AOR 00.63, 95% CI 00.47Á0.85). Adherence level did not differ based on ART outcome expectancies, ART attitudes, or the perceived necessity of ART. The overall model Optimal ART adherence is defined as 95% or greater percent of prescribed ART medications during the last month. Optimal ART adherence is defined as 95% or greater percent of prescribed ART medications during the last month.
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(x 2 075.70; p B0.001) indicated a high goodness-offit with the data.
Discussion
Findings reflect elevated rates of suboptimal adherence among an outpatient sample of HIV-infected individuals. More than one-third of participants endorsed suboptimal ART adherence during the last month, which may not maintain adequate viral suppression (Paterson et al., 2000) . Indeed, lower adherence levels were associated with having a detectable viral load at the last medical appointment. Suboptimal ART adherence increases the risk for adverse health outcomes and accelerated disease progression, underscoring the need to better understand mechanisms that may underlie poor adherence. Suboptimal adherence was more common among women, a finding consistent with a recent review, indicating lower ART adherence rates among HIV-infected women relative to men (Puskas et al., 2011) . However, the relationship between gender and ART adherence has been inconsistent, with other studies finding no difference in ART adherence levels by gender (Ammassari et al., 2002) . In addition, HIV-infected minority individuals also endorsed lower levels of adherence. This finding is consistent with the broader literature, suggesting disparities in HIV treatment and health outcomes among racial minorities (Cargill, Stone, & Robinson, 2004) . Poor adherence among women and minority individuals living with HIV is an important and a longstanding problem. Efforts to achieve and sustain optimal adherence in these vulnerable groups indicate that intervention approaches must be comprehensive and intensive (Holstad, DiIorio, Kelley, Resnicow, & Sharma, 2011; Simoni, Pantalone, Plummer, & Huang, 2007) .
An examination of SCT correlates indicated that ART adherence was associated with higher levels of adherence self-efficacy. Greater confidence in one's ability to maintain consistent ART adherence has been linked to higher ART adherence across a number of studies (Barclay et al., 2007; Catz et al., 2000; DiIorio et al., 2009; Fumaz et al., 2008) , highlighting the importance of self-efficacy as a predictor of consistent adherence. This finding underscores the need to assess ART adherence self-efficacy within ongoing HIV care and provide intervention approaches to improve patients' ability and confidence to maintain optimal levels of ART adherence. Patients who expressed the personal belief for lower levels of optimal ART adherence were more likely to report suboptimal adherence. Similarly, participants who reported lower levels of concern with a greater number of missed ART doses were also more likely to report poor adherence. Collectively, these two findings are of importance for patientÁprovider interactions. Care providers should understand that patients may develop their own personal beliefs about optimal adherence rates that differ from those provided by care providers. This suggests that providers should take time to assess patients' personal beliefs about ART adherence and address inaccurate beliefs regarding optimal ART adherence levels.
Contrary to expectations, adherence levels did not vary as a function of ART outcome expectancies and a measure of broader attitudes toward ART. Prior studies of ART outcome expectancies have produced mixed results. Several studies have shown an association between positive outcome expectancies and better ART adherence (Catz et al., 2000; Rudy et al., 2010) , and one has suggested that outcome expectancies were not directly related to adherence (DiIorio et al., 2009) . Differences in assessment measures and ceiling effects may account for some of the inconsistency in the relationship between outcome expectancies and adherence behavior.
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Limitations
This study is limited by its cross-sectional design. Thus, we could not examine the longitudinal impact of social-cognitive constructs on ART adherence and overall health functioning. In addition, our measure of ART adherence relied upon self-report data, which has inherent limitations (Simoni, Kurth, et al., 2006) , and focused on a single adherence level (i.e., 95% or greater adherence levels) over the course of the past month, which may not be representative of ART adherence patterns. Lower required levels of adherence to achieve viral suppression for specific regimen classes have been reported (Bangsberg, 2006; Bangsberg et al., 2007) and thus our cut-off adherence level may have been overly conservative for some prescribed regimens. In addition, measures of CD4 and viral load were collected from chart reviews of the last medical visit, and thus were not collected at the same time as the self-reported adherence measure for all participants. Finally, this sample consisted of HIV-infected individuals recruited from a mediumsized, northeastern city. Therefore, results may not generalize to the broader HIV-infected population.
Conclusions
Consistent with SCT, adherence problems in our sample were linked with deficits in self-efficacy as well as beliefs that do not support a goal of 100% adherence. SCT provides a framework for identifying patients at high risk for adherence problems and designing comprehensive behavioral interventions to increase ART adherence among HIV-infected individuals. According to SCT, the link between healthrelated cognitions (i.e., beliefs and intentions) and actual behavior are self-regulatory processes and skills (Bandura, 2005) . Thus, future SCT-informed interventions should target maladaptive adherencerelated cognitions, address skills to maintain consistent adherence, enhance self-efficacy, and improve self-regulation skills that facilitate the translation of positive intentions into sustained behavior. In addition, promotion of positive provider interactions surrounding adherence may bolster adherence selfefficacy .
